Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at JPMorgan Healthcare Conference Transcript

Jan 15, 2020 / 11:00PM GMT
Release Date Price: €48 (-1.03%)
Tejas Rajeev Savant
JP Morgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. My name is Tejas Savant, and I work on the life sciences team here at JPMorgan. It's my pleasure this afternoon to introduce Charles Kummeth, CEO of Bio-Techne. At the end of his presentation, there will be a breakout with management in the room next door, which is the Elizabethan C, I believe.

With that, I'd like to hand it over to Charles.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Thank you. Well, one thing I know is doing these at the very last day after 12 101s, you get a little hoarse. So sorry about that, but I'll try to speak out loud and that you can actually hear me. It's been a great -- it's been a busy 3 days as all you, I'm sure, are the same. I know you're all with me. I'm just glad it isn't raining this year, right?

So anyway, here's our first slide. We actually have a tagline now, where science intersects innovation. I think everyone likes to be an innovation company, but people -- some people

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot